|
NDUFS4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71404999999014E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.92270000001871E-06 |
| Normal-vs-Stage2 |
3.828800E-01 |
| Normal-vs-Stage3 |
6.15149999999565E-05 |
| Normal-vs-Stage4 |
6.31899999992136E-07 |
| Stage1-vs-Stage2 |
2.650000E-02 |
| Stage1-vs-Stage3 |
8.118400E-01 |
| Stage1-vs-Stage4 |
1.644200E-01 |
| Stage2-vs-Stage3 |
4.644300E-02 |
| Stage2-vs-Stage4 |
4.378000E-03 |
| Stage3-vs-Stage4 |
1.409790E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.47750000012437E-07 |
| Normal-vs-AfricanAmerican |
2.831900E-02 |
| Normal-vs-Asian |
1.635030E-04 |
| Caucasian-vs-AfricanAmerican |
1.967820E-01 |
| Caucasian-vs-Asian |
7.573600E-01 |
| AfricanAmerican-vs-Asian |
3.314200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.69526999999059E-05 |
| Normal-vs-Female |
4.30719999999774E-05 |
| Male-vs-Female |
2.889000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.60569999999582E-05 |
| Normal-vs-Age(41-60Yrs) |
9.51719999999767E-05 |
| Normal-vs-Age(61-80Yrs) |
9.804900E-04 |
| Normal-vs-Age(81-100Yrs) |
2.359500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.137400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.616400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.985200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.312800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.796600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.450400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.483200E-01 |
| Classical-VS-Follicular |
5.214900E-04 |
| Classical-VS-Other |
5.896800E-01 |
| Classical-VS-Normal |
1.75440000305116E-08 |
| Tall-VS-Follicular |
5.151000E-04 |
| Tall-VS-Other |
8.229000E-01 |
| Tall-VS-Normal |
6.15759999988974E-07 |
| Follicular-VS-Other |
1.556040E-01 |
| Follicular-VS-Normal |
3.228200E-01 |
| Other-VS-Normal |
9.104800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.354100E-04 |
| Normal-vs-N1 |
2.44540000027271E-07 |
| N0-vs-N1 |
1.002400E-02 |
|
|
